Carboxy Therapy Market Research Report and Outlook by 2028

The carboxy therapy market is projected to expand from US$ 85.24 million in 2021 to US$ 190.99 million by 2028, reflecting a compound annual growth rate (CAGR) of 12.4% from 2022 to 2028.

This report outlines the primary factors propelling market growth, key industry players, and their recent advancements. The increase in the carboxy therapy market is largely due to the rising popularity of non-invasive aesthetic treatments, a heightened demand for anti-aging solutions, and a growing elderly population. Nevertheless, the market faces challenges from regulatory frameworks and safety issues related to carboxy therapy.

Carboxy therapy involves the injection of carbon dioxide into targeted areas to enhance blood circulation. This non-surgical approach is gaining traction globally for treating conditions such as cellulite, stretch marks, and dark circles under the eyes.

In 2021, North America held the largest share of the market, driven by factors like the increasing interest in anti-aging treatments and a rise in non-invasive cosmetic procedures. According to the American Society for Aesthetic Plastic Surgery (ASAPS) in 2020, there were approximately 15.6 million cosmetic procedures performed, which included around 2.3 million surgical and 13.2 million minimally invasive procedures. Additionally, the International Society of Aesthetic Plastic Surgery reported that 174,300 photo rejuvenation procedures were conducted in the US in 2020. The expanding applications of carboxy therapy in various medical fields, including neurology, gynecology, and urology, are also expected to significantly boost market growth.

Moreover, evolving beauty standards, increased awareness regarding personal appearance, and higher disposable incomes in the region are anticipated to further stimulate market growth during the forecast period. Spending on aesthetic procedures has surged, with approximately US$ 20 billion allocated in 2020. Consequently, the rising number of aesthetic treatments and increased spending are likely to foster growth in the carboxy therapy market, providing substantial revenue opportunities in the coming years.

The carboxy therapy market is categorized by type into tabletop, portable, and others. The tabletop segment dominated the market in 2021, while the portable segment is expected to exhibit the highest CAGR of 12.6% during the forecast period.

In terms of application, the market is divided into aesthetic medicine, dermatology, gynecology, angiology, orthopedics and rheumatology, sports medicine, and others. The aesthetic medicine category, which includes treatments for cellulite, stretch marks, alopecia, and dark circles, held the largest market share in 2021. However, the dermatology segment is projected to grow at a notable CAGR of 12.9% during the forecast period.

Regarding end users, the market is segmented into hospitals, aesthetic clinics, and wellness centers. The hospitals segment was the largest in 2021, but the aesthetic clinics segment is anticipated to achieve the highest CAGR of 12.7% in the forecast period.

Impact of COVID-19 on the Carboxy Therapy Market

The COVID-19 pandemic led to various containment measures by the US government, which altered healthcare delivery and impacted the carboxy therapy market's growth. The pandemic resulted in the cancellation or postponement of elective surgeries to prevent the spread of SARS-CoV-2. Many aesthetic procedures, including anti-aging and facial rejuvenation treatments, were delayed as hospitals prioritized COVID-19 patients, leading to the suspension of nonessential operations. In May 2020, the American Society of Plastic Surgeons (ASPS) recommended halting elective and nonessential cosmetic and laser surgeries in the US.

However, with the rollout of numerous COVID-19 vaccines globally, the carboxy therapy market is expected to recover during the forecast period. Aesthetic procedure organizations are adapting by offering consultations through virtual platforms. The ASPS is promoting telehealth for preoperative consultations and postoperative follow-ups, indicating a shift in how services are delivered. Thus, while the pandemic negatively affected the carboxy therapy market, recovery is anticipated as conditions improve.

Companies in the carboxy therapy market are employing various organic and inorganic strategies to enhance their market presence. Organic strategies primarily involve product launches and approvals, while inorganic strategies include acquisitions, collaborations, and partnerships. These approaches enable market players to broaden their operations and strengthen their geographic reach, contributing to overall market growth. Notable developments in the carboxy therapy market include:

• In January 2020, Cosmo Pro Ltd. introduced the DIOX carboxytherapy system, which features a user-friendly touch-screen interface and offers both automatic and manual operation modes.

Key sources referenced in the preparation of this report include the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Food and Drug Administration (FDA).